| Literature DB >> 24485804 |
Yuko Yoshida1, Ryusuke Yoshimi1, Hiroaki Yoshii1, Daniel Kim1, Anup Dey1, Huabao Xiong2, Jeeva Munasinghe3, Itaru Yazawa4, Michael J O'Donovan4, Olga A Maximova5, Suveena Sharma6, Jinfang Zhu6, Hongsheng Wang7, Herbert C Morse7, Keiko Ozato8.
Abstract
Recent epidemiological studies have identified interferon regulatory factor 8 (IRF8) as a susceptibility factor for multiple sclerosis (MS). However, how IRF8 influences the neuroinflammatory disease has remained unknown. By studying the role of IRF8 in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, we found that Irf8(-/-) mice are resistant to EAE. Furthermore, expression of IRF8 in antigen-presenting cells (APCs, such as macrophages, dendritic cells, and microglia), but not in T cells, facilitated disease onset and progression through multiple pathways. IRF8 enhanced αvβ8 integrin expression in APCs and activated TGF-β signaling leading to T helper 17 (Th17) cell differentiation. IRF8 induced a cytokine milieu that favored growth and maintenance of Th1 and Th17 cells, by stimulating interleukin-12 (IL-12) and IL-23 production, but inhibiting IL-27 during EAE. Finally, IRF8 activated microglia and exacerbated neuroinflammation. Together, this work provides mechanistic bases by which IRF8 contributes to the pathogenesis of MS.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24485804 PMCID： PMC4105266 DOI： 10.1016/j.immuni.2013.11.022
Source DB: PubMed Journal: Immunity ISSN： 1074-7613 Impact factor: 31.745